MTOR and systemic lupus erythematosus: Our study identifies the non-coding intronic variant rs17673553 in CLEC16A as a critical contributor to SLE susceptibility, primarily through its effects on enhancer function, gene regulation, mTOR interaction, and autophagy modulation.